Skip to main content

Table 1 Characteristics of included studies

From: Photodynamic therapy versus anti-vascular endothelial growth factor agents for polypoidal choroidal vasculopathy: A meta-analysis

First Author (year) Design Center Location Type of OCT PDT anti-VEGF Sex(male/female) Agea(year) Follow- upa(mo)
No. eyes/patients No. eyes/patients PDT anti-VEGF
Mitamura(2010)22 Retro 1 Japan TD-OCT 49/49 22/22 7/42 5/17 73.0/69.6 3/3
Rouvas (2011)7 Retro 2 Greece SD-OCT 11/11 10/10 6/5 5/5 62.9/66.5 12/12
Koh (2012)21 RCT 7 Hong Kong, Singapore, Korea, Taiwan, Thailand TD-OCT 21/21 21/21 15/6 15/6 62.2/69.3 6/6
Oishi (2013)19 RCT 5 Japan SD-OCT 47/47 46/46 32/15 28/18 75.0/75.4 12/12
Inoue (2013)20 Retro 1 Japan SD-OCT 44/44 33/33 30/14 19/14 71.0/73.2 24/24
Kang (2014)18 Retro 1 Korea TD-OCT 19/19 23/23 NA NA 66.2/68.0 24/24
  1. aPDT group/anti-VEGF group
  2. PDT photodynamic therapy; VEGF vascular endothelial growth factor; mo months; Retro retrospective comparative study; TD-OCT time-domain optical coherence tomography; SD-OCT spectral-domain optical coherence tomography; RCT prospective randomized controlled